16 results
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... (PAMI) - Transdermal ... Medications # ... Management #Pain ... #Pharmacology #
Pain Assessment and Management Initiative (PAMI) - Procedural Sedation and Analgesia Medications 

#Management #Pain #Pharmacology #PSA
Pain Assessment ... and Management Initiative ... (PAMI) - Procedural ... #Management ... #Pain #Pharmacology
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... (PAMI) - Neuropathic ... Pain Medications ... #Pain #Pharmacology ... Dosing #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... and Management Initiative ... (PAMI) - Non-Opioid ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... and Management Initiative ... (PAMI) - Muscle ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Common Diabetes Medications ... GLP-1 Receptor Agonists ... • DPP4i / Gliptins ... #pharmacology # ... pathophysiology #endocrinology
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... and Management Initiative ... (PAMI) - Nerve ... #Pain #Pharmacology ... Nerve #Blocks #Medications
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... GLP-1 receptor agonists ... events TZDs DPP ... table #comparison #management ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... GLP-I receptor agonist ... Toxicities: • Joint pains ... #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... and Management Initiative ... (PAMI) - Intranasal ... #Pain #Pharmacology ... Dosing #Table #PAMI